Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New biochip predicts evolution of inflammatory bowel disease

27.01.2006


The treatment of inflammatory bowel disease, which includes Crohn’s disease and ulcerative colitis, has very high costs and can include admissions and surgical interventions. Until now, there was no precise tools to predict the evolution and prognosis of these diseases. A new biochip, IBDchip, (Inflammatory Bowel Disease DNA Chip) is a pioneering programme which has the aim to have a direct influence in the quality of life of patients.



This chip has been created by the biotechnology enterprise Progenika Biopharma, and IDIBAPS-Hospital Clínic de Barcelona has led the multicentre study which demonstrates the improving of the prognosis and therapeutics applied to patients with inflammatory bowel disease. Dr. Miquel Sans, from the Gastroenterology Department of Hospital Clínic and collaborator of the IDIBAPS group Physiopatology of gastrointestinal lesions has been in charge of the coordination of the trial and has participated, along with Dr. Carlos Cara, of UCB Pharma, in the development of the diagnostic chip.

This study had the participation of 579 patients (335 of which with Crohn’s disease and 344 with ulcerous colitis), and of the Central University Hospital of Asturias, University Clinical Hospital of Santiago de Compostela and Lozano Blesa Clinical Hospital of Zaragoza.


IBDchip includes the 61 polymorphisms that the scientific literature has until now associated to the inflammatory intestinal disease, the predisposition to suffer from it and its possible evolution. This is an open tool that can be updated while new related mutations are identified. To perform this diagnostic test, which uses laser technology, only a small blood sample of the patient is needed. IBCchip has been developed in the framework of the collaboration agreement signed in march 2004 between IDIBAPS and Cooperative Research Association in Biosciences of Biscay (CIC BIOGUNE). The inflammatory intestinal disease has an important genetic component, and it is estimated that there are 10 or 15 new cases per 100,000 inhabitants and year. In Spain, there are approximately 100,000 affected patients.

According to the study promoted by IDIBAPS- Hospital Clínic, in the Crohn’s disease, this microchip permits to predict with precision the localisation and extension of the pathology, the risk of suffering from the perianal disease, fistula or abscess, the possible need for surgery or the probability of having associated extraintestinal manifestations. In the case of ulcerative colitis, the IBDchip provides a large precision in the determination of the extension of the lesion, the need for a colectomy and the probabilities of associated extraintestinal manifestations. All this permits a more individualised treatment, with the aim to improve the quality of life of the patients. Furthermore, we must also emphasize the potential reduction in the health expense associated to the inflammatory bowel disease. In order to improve the study of the possibilities offered by the new diagnostic tool, Dr. Miquel Sans, of IDIBAPS-Hospital Clínic has promoted the creation of an European network which will have the participation of centres of 8 countries and will coordinate two more validation studies, held in the United States and in Japan.

Àlex Argemí Saburit | alfa
Further information:
http://www.idibaps.ub.edu

More articles from Life Sciences:

nachricht Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel

nachricht The Nagoya Protocol Creates Disadvantages for Many Countries when Applied to Microorganisms
05.12.2016 | Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

IHP presents the fastest silicon-based transistor in the world

05.12.2016 | Power and Electrical Engineering

InLight study: insights into chemical processes using light

05.12.2016 | Materials Sciences

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>